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Sunlnlal~ 
We analyzed the binding of an influenza matrix protein-derived peptide, MAT(17-31),  to cell 
surface and purified DR1. The pH dependence of peptide binding was dramatically influenced 
by the membrane environment. Cell surface binding was enhanced at low pH, with little or 
no binding detected at neutral pH and optimal binding at pH 4.  By contrast, hydrogen ion 
concentration had minimal effect on peptide binding to purified DR1. Exposure to low pH in 
the absence of peptide did not affect the peptide binding capacity of cell-associated DR1. Purified 
DR1 was stable at low pH, excluding the possibility that enhanced binding was offset by a competing 
denaturation event at low pH. The striking effect of pH on peptide binding characteristic  of 
cell surface DR1 was recovered after reconstitution of purified DR1 in B cell membranes by 
detergent dialysis. This behavior was partially  recovered by reconstitution of full-length, but 
not truncated DR1 in vesicles containing purified lipid. Our results demonstrate that interactions 
involving membrane components influence the peptide-binding behavior of Dt(1. 
C 
D4  T  lymphocytes recognize antigen-derived pep- 
tides bound to class II MHC molecules on the surface 
of APC. Studies with purified MHC proteins have contributed 
greatly to our current understanding of the binding events 
leading to the formation of peptide-class II MHC complexes 
(1, 2). Binding is specific, although individual class II pro- 
teins are capable of binding peptides with many different se- 
quences (3). The initial interaction of peptide with class II 
molecules to form unstable complexes may be rapid (4). How- 
ever, the rate of formation of stable complexes is quite slow, 
consistent with a mechanism that may involve a change in 
class II conformation (2, 4). The rate of peptide dissociation 
from stable complexes is also slow, often less than the physi- 
ological turnover rate of class II proteins in viable APC (5). 
Studies with mouse class II proteins have indicated that pep- 
tide binding is generally enhanced at acidic pH values that 
approximate the hydrogen ion concentrations found in en- 
dosomes and lysosomes (6-10).  Peptide binding is believed 
to occur in endosomal compartments in APC. Hydrogen ion 
concentrations in the range of pH 4-6 appear to enhance the 
association  rate  and  maximal extent  of binding without 
affecting the rate of dissociation of high affinity peptides (6-8, 
10). 
Studies to date suggest that the peptide-binding behavior 
of purified class II proteins in detergent micelles accurately 
reflects the behavior of molecules present in a normal mere- 
brane environment in APC. For example, the specificity of 
peptide binding observed with purified class II proteins cor- 
responds to known specificities defined by T  cells induced 
by in vivo immunization (11). The pH dependence of pep- 
tide binding observed with purified mouse class II proteins 
also corresponds to that observed in functional assays where 
T  cells are used to measure peptide binding to cell surface 
class II (10, 12,  13). There is  speculation, however,  that 
cofactors present in APC may influence the rate or degree 
of peptide/class II binding (6, 14). It is possible that molec- 
ular chaperones or other components present in physiolog- 
ical compartments may participate in peptide loading. 
Recent reports using several purified DR proteins raise the 
possibility that the peptide-binding activity of human class 
II molecules may be optimal at neutral pH (15-17).  These 
results call into question the hypothesis that vesicular acidi- 
fication is generally important in regulating peptide loading 
in human APC under physiological  conditions (12). 
In  the present  study,  we  analyzed  the binding of the 
influenza matrix peptide, MAT(17-31), to purified DR1 and 
found that binding was only slightly enhanced at acidic pH. 
The use of a recently developed assay (18) allowed us to directly 
measure binding of MAT(17-31) to cell surface DR1 on LG2 
B cells. Binding to cell surface DR1 was strikingly enhanced 
at low pH. Our results indicate that the peptide-binding be- 
havior of DR1 can be influenced by interactions involving 
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that studies with soluble class II proteins may not always ac- 
curately represent  their  physiological behavior. 
Materials  and Methods 
Purification and Reconstitution of DR1.  DILl was purified from 
the EBV-transformed homozygous LG-2 B cell line (DRBI*0101) 
using a monoclonal antibody LB3.1  (19) immunoafl~nity column 
as previously described (6). Samples were stored in buffer containing 
1%  N-octylglucoside  at  4~  and  analyzed by  SDS-PAGE  and 
Coomassie blue staining. Protein was determined using the bicin- 
choninic acid (BCA) assay (Pierce  Chemical Co., Rockford, IL). 
A soluble product of the purified DR1 membrane protein was gener- 
ated by digestion with papain as described by Gorga et al.  (20). 
Soluble recombinant DR1 was isolated from the conditioned cul- 
ture media of Sf9 insect cells infected with baculoviruses carrying 
truncated  c~ and B subunit  genes as described (19). 
In some experiments, DR1 (4.6/xM) was reconstituted into lipo- 
somes  from  solutions  containing  0.5%  N-octylglucoside  and 
purified lipid [500/~M dipalmitoylphosphatidylcholine (DP-PC), 
150 #M cholesterol (both from Sigma Chemical Co.,  St. Louis, 
MO)] by extensive dialysis against PBS. For other experiments,  DR1 
was reconstituted into mouse A20 B cell (21) membranes that were 
prepared after cell disruption by N2 cavitation as previously de- 
scribed (22).  The mouse class II proteins (LA  d and I-E  d) that are 
expressed in A20 do not bind MAT(17-31)  (data not shown). DR1 
(4.6 #M) was mixed with 0.5% N-octylglucoside-solubilized mem- 
branes (108 cell equivalents/ml) followed by dialysis to form lipo- 
somes. Liposomes were used directly in binding assays in the pres- 
ence of protease inhibitors. Each sample contained 2 pmol DR1, 
2.5  nmol DP-PC,  and  0.75  nmol cholesterol or  5  x  105 A20 
membrane equivalents. 
Peptide-Class  II Binding  Assay 
Solutions.  The solutions  in  this  assay include  the following: 
binding  buffer  =  100  mM  citrate/phosphate,  1  mM N-ethyl- 
maleimide, 5 mM EDTA, 1 mM iodoacetamide, 1 mM benzami- 
dine,  1 mM PMSF,  and 0.2% NP-40 for unreconstituted purified 
DR1 samples; TTBS  =  500 mM Tris, pH 7.5, and 0.1% Tween- 
20; MTB  =  5% skim milk, 1% BSA,  500 mM Tris pH 7.5 and 
0.1% Tween-20; MTBN  -- MTB  +  0.5% NP-40; neutralization 
buffer =  3.5% skim milk, 0.7% BSA, 335 mM Tris, pH 7.5, 0.07% 
sodium azide, 0.07%  Tween-20,  and 0.35%  NP-40;  lysis buffer 
=  0.5% NP-40, 0.15 M NaC1, 50 mM Tris, pH 8.0, and protease 
inhibitors; europium assay buffer  =  100 mM Tris, 0.15 M NaC1, 
1% sodium azide, 2 #M diethylenetriaminepentaacetic acid (Sigma 
Chemical Co.), 0.5%  BSA,  and 0.01%  Tween-40; enhancement 
solution A  =  1 M  acetate, pH 3.1,  60 mM benzoyl trifluoroace- 
tone, 850/xM Yttrium oxide (Y203; both from Sigma Chemical 
Co.), and 5% Triton X-100;  and enhancement solution B  =  2 M 
Tris, pH 7.0 and 200 mM 1,10-phenanthroline (Sigma Chemical 
Co.). 
Peptide.  MAT(17-31)  (23) (sequence;  SGPLKAEIAQRLEDV) 
was synthesized in the Emory University Microchemical Facility 
as previously described. The peptide was labeled with biotin by 
reaction with excess N-hydroxysuccinimide-biotin in dimethyl for- 
mamide  followed  by  precipitation  with  acetone  and  HPLC 
purification  (6). 
Preparation of Assay Plates.  Plates were coated with 100 #1 of 
20-#g/ml L243 mAb (DR~ specific) in borate buffered saline, pH 
8, overnight at 4~  Plates were blocked with MTB for 30 min 
at 24~  and washed with TTBS. 50 #1 MTBN was added to the 
plates before sample addition. 
Binding Reactions.  The binding assays using purified DR1 or 
reconstituted DR1 were performed with 2 pmol DR1 and various 
concentrations of biotin-MAT(17-31) at 37~  in microfuge tubes 
in a 30-/A volume of binding buffer with (purified DR1) or without 
(reconstituted DR1) detergent. The binding reaction was allowed 
to proceed for at least  18 h, and the pH was then neutralized by 
the addition  of an equal volume of neutralization  buffer. 
Peptide binding to cell surface DR1 was measured using 1  x 
106 LG2 cells/sample.  The cells were washed 2x  in  HBSS and 
fixed with 0.5% paraformaldehyde for 10 min at 24~  After ex- 
tensive washing in RPMI 1640 with 10% serum followed by PBS, 
the cells were incubated with biotin-MAT(17-31) in binding buffer 
lacking detergent.  After an 18-h incubation at 37~  cells were 
washed twice with HBSS and lysed for 40 min on ice in 60/xl 
lysis buffer.  The lysates were then cleared by centrifugation for 10 
rain at 20,000 g. 
Samples (purified,  reconstituted, or cell lysates) were applied to 
prepared microtiter plates for DR capture and quantitation of bound 
biotin-peptide. Samples were allowed to bind to the antibody-coated 
plates for 2  h  at 4~ 
Detection of  Peptide-Class II Complexes.  Bound biotinylated pep- 
tide was detected by washing the plate with TTBS and incubating 
with 100 ng/ml europium-labeled streptavidin (Wallac Oy, Turku, 
Finland) in assay buffer for 1 h at 4~  After washing,  100 ~1 of 
enhancement solution A was added per well and the plates  were 
shaken gently for 3 min at 24~  (24).  10/A of enhancement solu- 
tion B was added per well, and the plate was shaken again for 1 
min at 24~  Fluorescence of each sample well was measured at 
615 nm using a  1230 ARCUS  time-resolved fluorometer (LKB 
WaUac, Turku, Finland). The data points represent the mean fluores- 
cent counts per second/I,000 (cps  x  10 -a) of duplicate samples. 
The  procedures  used  allow comparison of relative  fluorescence 
within individual experiments but not between experiments. The 
assays involving cells especially showed day to day variation in signal 
magnitude, possibly due to fluctuations in DR1 surface expression 
or variation in reagents. The results shown in this communication 
are representative of at least three separate experiments. 
Western Blot Assay.  DR1 (0.5 #g/lane) was incubated in a 10 
/zl volume with 0.2% NP-40, 22 mM citrate/phosphate buffer at 
the indicated pH overnight at 37~  Samples were neutralized by 
the addition of 3 #1 1 M Tris, pH 7.0 before the addition of 4 #1 
nonreducing  4%  SDS  sample buffer and  incubated  for 20 rain 
without heating (Fig. 3, lane 8, sample was boiled). The samples 
were separated on linear  12%  SDS polyacrylamide gels by elec- 
trophoresis. Gels were run at 200 V for 50 min, and protein was 
transferred to nitrocellulose membranes for 18 min at 12 V in 25 
mM Tris, 192-mM glycine, pH 8.3, and 20% methanol. DR1 was 
detected with anti-DR rabbit serum, donkey anti-rabbit horseradish 
peroxidase and chemiluminescent substrate (ECL kit; both from 
Amersham International, Amersham, UK). The antisera used is 
fully cross-reactive with DR dimers and the dissociated monomers. 
The monomeric ot and 15 subunits co-migrate on the mini-gels used 
in these experiments. 
Results 
A  Difference in the Peptide-binding Behavior of Cell Surface 
and Purified, Detergent-solubilized DRI.  The results of experi- 
ments measuring the binding of biotin-labeled MAT(17-31) 
to purified DR1 indicate that binding is relatively insensitive 
to hydrogen ion concentrations in the range of pH 7-4 (Fig. 
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reported by Mouritsen et al. (16). The data are representative 
of more than 15 experiments and a similar pH dependence 
of binding was observed over a range of peptide concentra- 
tions from 40 nM to  10 #M. 
The fluorescence assay used to measure the binding of  biotin- 
labeled peptide to purified DR1 (Fig. 1 a) allowed us to also 
measure binding of peptide to cell-associated DR.1. We have 
previously demonstrated that this assay is specific, highly sen- 
sitive,  and linear over a large concentration range of pep- 
tide-class II complexes (18). Fixed LG2 B cells (homozygous 
for DR1) were incubated with biotin-MAT(17-31) in 0.15 M 
citrate/phosphate buffer containing protease inhibitors. After 
washing, detergent lysates were prepared and transferred to 
microtiter plates coated with the mAb, L243, to selectively 
capture DR-peptide complexes. Bound biotin-peptide was 
detected with streptavidin-europium followed by measure- 
ment of time-resolved fluorescence. Binding was inhibited 
in the presence of excess unlabeled peptide and only small 
background signals were observed with samples lacking biotin- 
peptide  or  captured  with  inappropriate  mAb  (Fig.  1  b). 
Significant signals were obtained with biotin-peptide con- 
centrations <1/zM after incubation for 18 h  at 37~  We 
conclude  that  the  fluorescence immunoassay  specifically 
measures the binding of peptide to DR1. 
Binding of biotin-MAT(17-31)  to cell surface DR1  was 
markedly enhanced at low pH (Fig.  1 c). Binding was essen- 
tially undetectable at neutral pH and increased as the hydrogen 
ion concentration was increased to reach a maximum at pH 
4 or pH 4.5.  Similar results were obtained in nine experi- 
ments and with biotin-peptide concentrations ranging from 
0.1  to  10 ttM. 
Peptide Binding Is Unaffected by Pretreatment of DR1 at Low 
pH.  Pretreatment of fixed LG2 cells in buffer at pH 5 for 
up to 3 d had no appreciable effect on the degree of peptide 
binding measured at pH 7 (Fig.  2).  These results rule out 
the possibility that enhanced binding at low pH on cells is 
due to an increase in binding sizes resulting from the acid- 
induced dissociation of loosely bound peptides. 
We have previously proposed that murine class II mole- 
cules undergo a conformational change at acidic pH, resulting 
in a flexible molecule that is better able to bind peptide (6, 
7).  It is possible that the flexible form of purified DR1  at 
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Figure  2.  Pretreatment of fixed cells at acidic pH does not enhance pep- 
tide binding at neutral pH. Fixed LG2 cells were incubated at 37~  for 
1 (open bars), 2 (gray bars), or 3 d (solid bars) in 150 mM citrate/phosphate 
at pH 5 or 7. After washing, the cells were incubated with 1/zM biotin- 
MAT(17-31) in 150 mM citrate/phosphate at pH 5 or 7 at 37~  for 18 h. 
Binding of peptide to DR1 was determined as described in Materials  and 
Methods. 
low pH is unstable and rapidly denatures. The dissociation 
of the class II heterodimer at low pH may counteract en- 
hanced peptide binding, resulting in the relatively flat pH 
curve observed with purified DR1. 
To address this possibility, the stability of purified DR1 
was measured by incubation at various pH for 18 h at 37~ 
(Fig.  3 a). Unboiled samples were resolved on SDS-PAGE 
to  determine  the  extent  of subunit  dissociation  to  form 
monomers. The fraction of monomers was only marginally 
increased with incubation under acidic conditions as low as 
pH 4. Thus, no gross destabilization of purified DR1 is ob- 
served at low pH. 
It is likely that only "empty" DR1 molecules are available 
for peptide binding, and this subpopulation is believed to be 
unstable in SDS (19,  25,  26).  The small fraction of empty 
molecules in the total pool of purified DR1 may not be de- 
tected by SDS-PAGE analysis. The potential loss of functional 
DR1 molecules was therefore analyzed by a 48-h treatment 
of purified DR1  at low pH in the absence of peptide fol- 
lowed by measurement of residual binding activity in an 18-h 
assay (Fig. 3 b). Binding activity was completely retained after 
incubation in acidic buffer as low as pH 4. All activity was 
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Figure  1.  Effect ofpH on binding of MAT(17-31) 
to purified,  detergent solubilized DR.1 and cell sur- 
face DR1. (a) Purified DILl was incubated with 1 #M 
biotin-MAT(17-31)  in 0.2% NP-40 and 100 mM ci- 
trate/phosphate at the indicated pH for 18 h at 37~ 
(b) Fixed LG2 cells were incubated with or without 
1/zM biotin-MAT(17-31) in 150 mM citrate/phosphate, 
pH 5 for 18 h at 37~  In one sample,  100/zM unla- 
beled MAT(17-31) was added to show specificity of 
binding. After washing, the cells were lysed and added 
to microtiter assay plates coated with L-243 or 14-4-4 (control mAb). (c) Fixed LG2 cells were incubated with 1/zM biotin-MAT(17-31) in 150 mM 
citrate/phosphate at the indicated pH for 18 h at 37~  Biotinylated peptide binding to DR1 was measured with europium-streptavidin fluorescence 
as described  in Materials  and Methods. 
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tide binding activity of purified  DR1.  (a)  Purified DR1 was incubated 
for 18 h in a 10-/zl volume of 20 mM citrate/phosphate  at the indicated 
pH. Samples were neutralized  with 3 #1,  1 M  Tris, pH 7.0 for 10 min 
before the addition of 4% SDS sample buffer. One sample, pretreated  at 
pH 7.0, was boiled for 5 rain before electrophoresis  on a 12% polyacryl- 
amide gel.  A Western  blot was used to measure the relative proportion 
of  class II dimers (/9) and dissociated  monomers (M) as described in Materials 
and Methods.  (b)  Purified DR1 was incubated  in  10 mM citrate/phos- 
phate at the indicated  pH for 2 d at 37~  The pH was brought to 5.0 
by adding  100 mM (final) citrate/phosphate  pH 3.0,  and 1 ~M biotin~ 
MAT(17-31) was added.  After 18 h at 37~  peptide  binding was mea- 
sured  as described  in Materials  and  Methods. 
lost  after  incubation at pH  3,  consistent with irreversible 
denaturation of functional molecules. We conclude that the 
relatively small effect of low pH on peptide binding by purified 
DR1  is not accounted for by a competing reaction where 
functional molecules are irreversibly  denatured. 
Reconstitution of  pH-dependent Peptide  Binding.  The observed 
difference in the peptide-binding behavior of purified DR1 
as compared to cell surface DR1 could reflect the selection 
of a subpopulation of molecules during the purification pro- 
cedure, which involves exposure to various detergents, high 
concentrations of salt, and high pH. Alternatively,  the pro- 
tein may undergo irreversible structural alteration during iso- 
lation resulting in altered  behavior. 
These latter possibilities were excluded by the observation 
that the pH-dependence of peptide binding that is character- 
istic of cell surface DR1 was recovered after reconstitution 
of purified DR1 in liposomes containing B cell membrane 
components (Fig. 4 a). Purified DR1 was added to detergent- 
solubilized membranes that were isolated from murine A20 
B cells and liposomes were formed by detergent dialysis. Similar 
results were obtained in five experiments. Maximal binding 
after reconstitution ranged from ~o45 to 140% as compared 
with control DR1 preparations in 0.2%  NP-40 detergent. 
Inaccessibility of a fraction of the reconstituted DR1 resulting 
from orientation in the membrane bilayer of the liposomes 
may partially account for this variation. The observed recovery 
of pH-dependent binding activity in these experiments also 
excluded  the formal possibility that the fixation  procedure 
used in experiments with intact LG2 B cells artifactually  al- 
tered peptide binding behavior. 
Interactions between DR1 and specific cofactors in B cell 
membranes are not required for partial reconstitution of pH- 
dependent binding behavior. The relative pH dependence of 
binding was partially, although not completely, recovered after 
reconstitution into lipid vesicles  containing only phosphatidyl 
choline and cholesterol (Fig.  4 b). Direct addition of lipid 
to detergent-containing solutions of DR1 did not significantly 
influence peptide-binding behavior (Fig. 4 c), indicating that 
restoration of the pH dependence requires  the presence of 
a lipid bilayer. These results  suggested that the insertion of 
DR1 into a lipid bilayer is suffacient  to confer enhanced binding 
activity at acidic pH. This conclusion was further substan- 
tiated in control experiments using truncated forms of DR1. 
Recovery of pH-dependent peptide binding was not observed 
after  mock-reconstitution of recombinant (19) or papain- 
digested (20) DR1, lacking the transmembrane and cytosolic 
domains (data  not shown). 
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Figure  4.  The pH dependence of MAT(17-31) 
binding  can  be  recovered  by  reconstitution  of 
purified DR1 into membrane  vesicles. (a)  1.5  x 
106 fixed LG2 (open circles), 2 pmol purified DR1 
in NP-40 micelles (closed  circles), or 2 pmol purified 
DR1 reconstituted  into mouse B cell (A20) mem- 
branes  (open squares) were incubated  with  1/~M 
biotin-MAT(17-31) in 100 mM citrate/phosphate 
at  the indicated  pH for  18  h  at  37~  Peptide 
binding was measured as described in Materials and 
Methods  and  expressed as percent  of maximum 
binding for each preparation.  Maximum binding for fixed cells, 328; detergent micelles, 920; and reconstituted  DR1, 418 cps  x  10 -3.  (b) Binding 
of biotin-MAT(17-31)  to DR1 in fixed/s  (open circles), detergent micelles (closed circles), and vesicles containing DP-PC and cholesterol (open triangles) 
was measured at various pH and expressed as described above. Maximum binding for fixed cells, 282; detergent micelles, 277; and reconstituted  DR1, 
552 cps  x  10 -3.  (c) Purified  DR1 was  incubated  with  (open circles) and  without (closed circles) 2.5  nmol DP-PC and  0.75  nmol cholesterol  in  100 
mM citrate/phosphate,  0.2% NP-40 and 1 #M biotin-MAT(17-31)  at the indicated pH. After 18 h at 37~  bound peptide was measured as described 
in Materials  and  Methods. 
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In this report we have shown that the pH dependence of 
binding of MAT(17-31) to DR1 is drastically different de- 
pending on the presence of a lipid bilayer. The peptide binding 
activity of purified DR1 in detergent micelles is relatively 
independent of pH in the physiological range. By contrast, 
cell-associated DR1  or purified DR1  that has been recon- 
stituted into B cell membranes shows a striking pH depen- 
dence with optimal binding at pH 4-4.5. 
The increase in peptide binding observed at low pH with 
cell-associated DR1 could not be attributed to an increase 
in available binding sites after acid stripping  of loosely as- 
sociated peptides.  No  major enhancement or decrease in 
binding activity was observed after extensive pretreatment 
of fixed B cells with low pH.  This was further confirmed 
by the observation that pH-dependent binding could be re- 
covered after reconstitution of purified DR1 into lipid mem- 
branes. The latter result also excluded potential effects of fixa- 
tion on cell surface DR1 binding behavior and the possibility 
that pH-dependent peptidase activity associated with the cell 
membrane was responsible for decreased peptide-DR1 com- 
plex formation at neutral pH. 
We also considered the possibility that purified DR1 may 
be relatively unstable at low pH with enhanced o~/~ subunit 
dissociation  and irreversible denaturation. Dornmair et al. 
(27) have provided evidence that IE  k may be more sensitive 
to acid-induced denaturation in the absence of a lipid bilayer. 
Subunit  dissociation could offset any advantage in peptide 
binding provided by a low pH environment. However, the 
major fraction of purified DR1 dimers was found to be rela- 
tively stable during incubation in acidic buffer as low as pH 
4 (Fig. 3). The capacity of DR1 to bind peptide, reflecting 
the functionally relevant subset of molecules, was unaffected 
by exposure to low pH. 
The pH dependence of peptide binding observed with cells 
but not with detergent-solubilized  protein can be substan- 
tially recovered by reconstitution of purified DR1 into lipid 
vesicles. It is possible that full recovery of the peptide binding 
behavior characteristic of cell surface DR1 may be achieved 
by altering the constituent lipids used in detergent dialysis. 
Thus, a mechanism involving pH-dependent interaction be- 
tween DR1 or peptide  and a specific cofactor(s) present in 
B cell membranes is not required to account for differences 
in peptide binding between cell surface and purified DR1. 
However,  the potential  contribution of a specific cofactor 
cannot be excluded and we are addressing this possibility with 
ongoing experiments. Roof et al. (28) reported that a variety 
of lipids, including PC, enhance the binding of peptides to 
purified class II glycoproteins in detergent. This effect does 
not appear to account for the enhanced binding observed at 
low pH after reconstitution of DR1 in lipid vesicles. Direct 
addition of equivalent amounts of lipid to DR1 in detergent 
had no effect on peptide binding. Furthermore, the peptide- 
binding activity of reconstituted DR1 was not enhanced at 
neutral pH in contrast to the results of Roofer al. (28). How- 
ever, mouse class II proteins  were used in their study and 
it is possible that altering the lipid of composition or increasing 
lipid concentration may result in formation of specific class 
II/lipid'interactions that mimic conditions found in cellular 
membranes. 
Our data support the conclusion that interactions between 
the transmembrane domain of DR1  and the lipid  bilayer 
influence the overall structure of the protein with an effect 
on the conformation or flexibility of the spatially distant o~1 
and ~1 domains that directly interact with peptide, pH-depen- 
dent peptide binding was not recovered  after mock-reconstitu- 
tion with soluble forms of DR1 lacking the transmembrane 
and cytosolic domains. This suggests that the presence of de- 
tergent, per se, does not account for the altered  peptide binding 
behavior of purified full-length DR1.  Our data are consis- 
tent with a model in which the lipid bilayer and the trans- 
membrane domain of Dkl interact to stabilize a rigid con- 
formation that does not favor peptide binding. Low pH may 
be  required  to  induce  a  more  flexible conformation in 
membrane-bound, but not soluble, DR1  molecules. 
Interactions involving the transmembrane domains do not 
appear to affect the peptide-binding behavior of several  mouse 
class II proteins that have been studied. The pH dependence 
of peptide  binding observed in experiments  with purified 
IA  d, IA  k, IE  d, and IE  k in detergent (6, 7) is very similar to 
that inferred from experiments in which binding to cell sur- 
face class II was indirectly measured using functional assays 
(12). The characteristic pH dependence of  binding is also con- 
served in studies with a recombinant phosphatidylinositol- 
anchored form of IE  k (8, 13). We speculate that interactions 
involving the transmembrane domains may have greater or 
lesser influence on peptide binding activity depending on sta- 
bility of interactions between the extracellular domains. Al- 
ternatively, the interactions involving the transmembrane do- 
mains of DR1 may be more sensitive to changes in hydrogen 
ion concentration. This could be tested by analysis of chi- 
meric class II  proteins  after  exchange  of transmembrane 
domains. 
Sette et al. (15) reported that the binding of several  different 
peptides  to purified DR1,  DR5,  and DR7 was relatively 
unaffected by hydrogen ion concentration in the range of pH 
4-7. This may be a property of many DR proteins in deter- 
gent. However, a marked enhancement of peptide binding 
at low pH was observed with DR3 in detergent (29). It is 
possible that peptide binding is generally optimal at low pH 
for DR proteins expressed in their normal membrane envi- 
ronment in APC. This is consistent with the hypothesis that 
peptide loading occurs in acidic endosomal  compartments 
under physiological  conditions. We have preliminary evidence 
that cell-associated DR1 preferentially binds peptides other 
than MAT(17-31) at low pH. Further studies will be required 
to test the generality of this observation. However, the data 
presented in the present report clearly demonstrate that in- 
teractions  between DR1  and  membrane components can 
influence peptide-binding behavior. 
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